Nancy Krieger1, Jarvis T Chen, Pamela D Waterman. 1. Department of Society, Human Development, and Health, Harvard School of Public Health, Kresge 717, 677 Huntington Avenue, Boston, MA 02115, USA. nkrieger@hsph.harvard.edu
Abstract
OBJECTIVE: For at least three decades, many investigators have reported on the US black/white breast cancer case ratio for estrogen receptor (ER) status as if it reflected an intrinsic biological difference. In light of racial/ethnic differences in declines in the incidence of ER+ breast cancer, as linked to changing use of hormone therapy, we empirically tested whether the black/white breast cancer estrogen receptor ratio has changed over time. METHODS: We examined temporal trends in the odds of being ER+ among white as compared to black women among all cases of invasive breast cancer occurring among women residing in the catchment area of the SEER 13 Registries Database between 1992 and 2005. RESULTS: During the study period, the odds of being ER+ among the white compared to black cases increased from 1992 to 2002 (a statistically significant joinpoint; p < 0.05; peak odds ratio (2002) = 2.25 (95% confidence interval 2.13, 2.39)). Thereafter, the odds ratio leveled off (post-2002 slope not significantly different from zero; p = 0.326). Among women aged 45-54, moreover, the post-2002 decline tended toward statistical significance (p = 0.0891). CONCLUSIONS: The results suggest the black/white breast cancer case estrogen receptor ratio is historically contingent, not innate.
OBJECTIVE: For at least three decades, many investigators have reported on the US black/white breast cancer case ratio for estrogen receptor (ER) status as if it reflected an intrinsic biological difference. In light of racial/ethnic differences in declines in the incidence of ER+ breast cancer, as linked to changing use of hormone therapy, we empirically tested whether the black/white breast cancerestrogen receptor ratio has changed over time. METHODS: We examined temporal trends in the odds of being ER+ among white as compared to black women among all cases of invasive breast cancer occurring among women residing in the catchment area of the SEER 13 Registries Database between 1992 and 2005. RESULTS: During the study period, the odds of being ER+ among the white compared to black cases increased from 1992 to 2002 (a statistically significant joinpoint; p < 0.05; peak odds ratio (2002) = 2.25 (95% confidence interval 2.13, 2.39)). Thereafter, the odds ratio leveled off (post-2002 slope not significantly different from zero; p = 0.326). Among women aged 45-54, moreover, the post-2002 decline tended toward statistical significance (p = 0.0891). CONCLUSIONS: The results suggest the black/white breast cancer case estrogen receptor ratio is historically contingent, not innate.
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Christina A Clarke; Theresa H M Keegan; Juan Yang; David J Press; Allison W Kurian; Anish H Patel; James V Lacey Journal: J Natl Cancer Inst Date: 2012-07-05 Impact factor: 13.506
Authors: Whitney R Robinson; Hazel B Nichols; Chiu Kit Tse; Andrew F Olshan; Melissa A Troester Journal: Am J Epidemiol Date: 2016-08-23 Impact factor: 4.897
Authors: Azadeh Stark; Robert Stapp; Aditya Raghunathan; Xiaowei Yan; H Lester Kirchner; Jennifer Griggs; Lisa Newman; Dhananjay Chitale; Andrew Dick Journal: Breast Cancer Res Treat Date: 2011-08-27 Impact factor: 4.872
Authors: Theresa H M Keegan; Mindy C DeRouen; David J Press; Allison W Kurian; Christina A Clarke Journal: Breast Cancer Res Date: 2012-03-27 Impact factor: 6.466
Authors: Sandra Del Pino; Sol Beatriz Sánchez-Montoya; José Milton Guzmán; Oscar J Mújica; Juan Gómez-Salgado; Carlos Ruiz-Frutos Journal: Int J Environ Res Public Health Date: 2019-09-08 Impact factor: 3.390
Authors: Nancy Krieger; Laurel A Habel; Pamela D Waterman; Melina Shabani; Lis Ellison-Loschmann; Ninah S Achacoso; Luana Acton; Stuart J Schnitt Journal: NPJ Breast Cancer Date: 2015-10-07